Investment Of Rs 200 Cr For Medicinal Plant Sector Of NE: Sonowal

Jorhat: Union minister Sarbananda Sonowal on Sunday said investment to the tune of around Rs 200 crore will be made in the CSIR-North East Institute of Science and Technology (NEIST) to build capacity for the medicinal plant sector of the region.

The amount is aimed at creating infrastructure that will boost medicinal plant storage for commercial purpose, strengthen research and development of local herbs and plants for medicinal purpose, as well as provide a platform for traditional healers to further their treatment to a wider section of the society, an official release said.

Sonowal, the Union Minister of Ayush, made the announcement at CSIR-NEIST.

The NEIST at Jorhat, formerly known as Regional Research Laboratory, is a constituent establishment of the Council of Scientific and Industrial Research (CSIR).

“The rich bounty of nature of North East must be used responsibly so that the ecology of the region is sustained, while the medicinal benefits from the herbs can be extracted responsibly to ramp up India’s rich heritage in traditional medicine,” Sonowal said.

“We are revitalising the traditional medicine with a rational approach to scientifically validate its outcome so that more and more people can avail its life-enriching benefit. As India leads the resurgence of traditional medicine globally, the North East will play a crucial role to act as harbinger of growth for the healing industry of India,” he said.

During the visit, the minister reviewed the progress of different activities undertaken by the institute to strengthen the potential of medicinal plant market in the region, the release added.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states